此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer Survivors (SURBCAN)

2019年2月19日 更新者:Maria Sala、Parc de Salut Mar
The increased likelihood of survival can be explained by numerous factors, such as improvements in breast cancer screening and advances in diagnosis and treatment and aging. This phenomenon is associated with comorbidity due to cancer treatment and external factors like aging or lifestyle. Little is known about how these women follow-up their disease, their pattern of use of health resources and their met and unmet needs. Studying the health needs of these women is a cancer-related priority for Cancer Organizations.The project is aimed at: 1) Describing the comorbidities and patterns of use of primary and specialized care in women who have survived a breast cancer for at least five years; 2) Comparing the comorbidities and patterns of use of long time breast cancer survivors with women without a cancer diagnosis; and 3) Estimating the use of resources in long time survivors of breast cancer adjusted for survival-time and comorbidities.

研究概览

地位

完全的

条件

详细说明

The general objective of this study is to analyze the pattern of comorbidities and utilization of primary care officers and specialized attention of long-term breast cancer survivors and to compare it with women without history of cancer. Long-term breast cancer survivors are those women who survived for at least five years since de primary breast cancer diagnosis.The use of health care services for long-term breast cancer survivors presents new challenges for health systems in terms of defining the role of each health professional and each level of care in contact with these women during their follow-up.

The SURBCAN Project is an observational study that includes a retrospective cohort of women from five Spanish areas. The study is based on Real World Data from clinical history and tumor registration. Women with a diagnosis of breast cancer and a survival period of ≥ 5 years were identified, as well as those women without a cancer diagnosis and matched by age and area with breast cancer survivors (1:2). N= 21639 women (7241 cases /13,398 controls). Sociodemographic and clinical variables were included. The use of primary care and hospital attention and the presence of comorbidities were assessed during the follow-up period (2012-2016). The basal cohort, the comorbidities and the use of health services were described. Factors associated with use were analyzed through multi-level logistic regression models.

Expected results: Nowadays there are no results of cohort analysis that focus specifically in long-term breast cancer survivors. The SURBCAN study will provide evidence regarding comorbidity patterns and follow-up characteristics. The results will guide the elaboration of new recommendations and the decision making by stakeholders concerned to breast cancer survivor's follow-up.

This project combines the experience from experts groups in health services assessment, and analysis of comorbidities and chronic diseases, belonging to the REDISSEC network.

研究类型

观察性的

注册 (实际的)

21639

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不适用

有资格学习的性别

女性

取样方法

非概率样本

研究人群

Women with a diagnosis of breast cancer (during 2000 until 2006) with a survival period of ≥ 5 years that had a visit with the healthcare services during the period from 2012 to 2016 were identified, as well as those women without a cancer diagnosis and matched by age and area with breast cancer survivors.

描述

Inclusion Criteria:

  • >18 years old
  • Women diagnosed with an incident breast cancer during the period from 01/01/2000 until 31/12/2006 who survived for at least 5 years.
  • Women who visited at least once the primary health services during follow-up period (01/01/2012 to 31/12/2016).

Exclusion Criteria:

- Unknown diagnostic year

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Long-term breast cancer survivors

Analyze comorbidities and patterns of use of health services. Describe the specific use of health services in primary care vs. specialized care.

Analyze comorbidities and patterns of use of health services by tumor characteristics.

Women without history of cancer
Analyze comorbidities and patterns of use of health services. Describe the specific use of health services in primary care vs. specialized care.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Frequency of comorbidities
大体时间:5 years of survival
Number of comorbidities of each woman at five-year survival from breast cancer. Assessed through ICD10.
5 years of survival
Frequency of visits to healthcare services
大体时间:5 years of survival
Number of visits to primary care attention or specialised attention done by each women at five-year survival from breast cancer.
5 years of survival
Main health provider visited
大体时间:5 years of survival
Leading provider of health services (GP, oncologist, community nurse, oncology nurse, physiotherapist...) of each women at five-year survival from breast cancer.
5 years of survival

次要结果测量

结果测量
措施说明
大体时间
Frequency of visits to primary care attention
大体时间:at 5 years of survival
Number of visits to primary care attention done by each women at five-year survival from breast cancer.
at 5 years of survival
Frequency of visits to specialized care attention
大体时间:at 5 years of survival
Number of visits to specialised attention done by each women at five-year survival from breast cancer.
at 5 years of survival
Annual mammogram frequency
大体时间:1 year
Assessment of the percentage of women who have a mammogram every year.
1 year

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2012年1月1日

初级完成 (实际的)

2012年1月1日

研究完成 (实际的)

2016年12月31日

研究注册日期

首次提交

2019年2月13日

首先提交符合 QC 标准的

2019年2月19日

首次发布 (实际的)

2019年2月20日

研究记录更新

最后更新发布 (实际的)

2019年2月20日

上次提交的符合 QC 标准的更新

2019年2月19日

最后验证

2019年2月1日

更多信息

与本研究相关的术语

其他研究编号

  • SURBCAN Project

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅